DL-2,5-dioxooxazolidine-4-pentanoic acid | 98839-13-5

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: DL-2,5-dioxooxazolidine-4-pentanoic acid
• 英文别名: 2,5-Dioxo-4-oxazolidinepentanoic acid；5-(2,5-dioxo-1,3-oxazolidin-4-yl)pentanoic acid
• CAS: 98839-13-5
• 化学式: C₈H₁₁NO₅
• 分子量: 201.179
• InChiKey: SBYXQXFEAFAPNS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.1
• 重原子数：
  14
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.62
• 拓扑面积：
  92.7
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  L-丙氨酸 、 DL-2,5-dioxooxazolidine-4-pentanoic acid 在 sodium hydroxide 、 碳酸氢钠 、 sodium carbonate 作用下， 以 水 为溶剂， 以31%的产率得到(L-2-aminopimelyl)-L-alanine
  参考文献：
  名称：

  Peptides of 2-aminopimelic acid: antibacterial agents that inhibit diaminopimelic acid biosynthesis

  摘要：

  Succinyl-CoA:tetrahydrodipicolinate-N-succinyltransferase is a key enzyme in the biosynthesis of diaminopimelic acid (DAP), a component of the cell wall peptidoglycan of nearly all bacteria. This enzyme converts the cyclic precursor tetrahydrodipicolinic acid (THDPA) to a succinylated acyclic product. L-2-Aminopimelic acid (L-1), an acyclic analogue of THDPA, was found to be a good substrate for this enzyme and was shown to cause a buildup of THDPA in a cell-free enzyme system but was devoid of antibacterial activity. Incorporation of 1 into a di- or tripeptide yielded derivatives that exhibited antibacterial activity against a range of Gram-negative organisms. Of the five peptide derivatives tested, (L-2-aminopimelyl)-L-alanine (6) was the most potent. These peptides were shown to inhibit DAP production in intact resting cells. High levels (30 mM) of 2-aminopimelic acid were achieved in the cytoplasm of bacteria as a result of efficient uptake of the peptide derivatives through specific peptide transport systems followed, presumably, by cleavage by intracellular peptidases. Finally, the antibacterial activity of these peptides could be reversed by DAP or a DAP-containing peptide. These results demonstrate that the peptides containing L-2-aminopimelic acid exert their antibacterial action by inhibition of diaminopimelic acid biosynthesis.

  DOI：

  10.1021/jm00151a015
• 作为产物：
  描述：

  光气 、 DL-2-氨基庚二酸 在 氩 、 光气 、 乙醇 、 petroleum ether 作用下， 以 甲苯 为溶剂， 反应 17.0h， 以to give 1.6 g of the desired product的产率得到DL-2,5-dioxooxazolidine-4-pentanoic acid
  参考文献：
  名称：

  Method of inhibiting a .beta.-lactamase enzyme by administering novel

  摘要：

  本发明涉及一般式为##STR1##的碳青霉烯类抗生素化合物，其中基团##STR2##是4、5或6成员的单、二或三取代氧或硫含环；其中Z是氧、硫、亚砜和磺酰基，所述药物组成物对治疗细菌感染有用，通过给予所述化合物抑制β-内酰胺酶酶的方法，揭示了制备该化合物的过程以及在该过程中有用的新中间体。

  公开号：

  US05744465A1

文献信息

• 2-thiosubstituted carbapenems
  申请人：American Cyanamid Company

  公开号：US05602118A1

  公开（公告）日：1997-02-11

  Carbapenem antibiotic compounds of the general formula: ##STR1## wherein the moiety ##STR2## is a 4, 5 or 6 membered mono, di- or tri- substituted oxygen or sulfur containing ring; wherein Z is oxygen, sulfur, sulfoxide and sulfone, pharmaceutical compositions thereof useful for the treatment of bacterial infections, processes for preparing the compounds and new intermediates useful in the process.

  一般公式为：##STR1##，其中基团##STR2##是4、5或6元素的单、双或三取代氧或硫含环；其中Z是氧、硫、亚硫氰和砜，用于治疗细菌感染的药物组合物，制备该化合物的方法以及在该过程中有用的新中间体。
• New 8-substituted derivatives of an anhydrooctonic acid, methods for their preparation, pharmaceutical preparations containing these and intermediates
  申请人：Astra Läkemedel Aktiebolag

  公开号：EP0234178A1

  公开（公告）日：1987-09-02

  Novel compounds of the formula wherein Y is hydrogen, halogen, amino, acylamino, acyloxy, azido, mercapto, thiocarboxy, the groups in which AA is an amino acid or peptide and W is OH or the same as AA; or physiologically acceptable salts thereof, processes for their preparation, pharmaceutical preparations containing the compounds, use of the compounds, and methods for treatment, and chemical intermediates. The compounds are active as enzyme inhibitors and useful as antibacterial agents or as intermediates for preparing antibacterial agents.

  新化合物的公式，其中Y是氢、卤素、氨基、酰胺基、酰氧基、叠氮基、巯基、硫代羧基的基团，AA是氨基酸或肽，W是OH或与AA相同；或其生理上可接受的盐，其制备方法，含有这些化合物的药物制剂，这些化合物的用途，治疗方法和化学中间体。这些化合物作为酶抑制剂活性，并可用作抗菌剂或用于制备抗菌剂的中间体。
• Method for producing tetrahydrofuranyl compounds
  申请人：——

  公开号：US05623081A1

  公开（公告）日：1997-04-22

  Tetrahydrofuanyl compounds of the following formulae: ##STR1## are disclosed.

  披露了以下式子的四氢呋喃基化合物：##STR1##。
• Method of inhibiting a .beta.-lactamase enzyme by administering novel
  申请人：American Cyanamid Company

  公开号：US05744465A1

  公开（公告）日：1998-04-28

  Carbapenem antibiotic compounds of the general formula: ##STR1## wherein the moiety ##STR2## is a 4, 5 or 6 membered mono, di- or tri- substituted oxygen or sulfur containing ring; wherein Z is oxygen, sulfur, sulfoxide and sulfone, pharmaceutical compositions thereof useful for the treatment of bacterial infections, method of inhibiting a Beta-lactamase enzyme by administering said compounds, processes for preparing the compounds and new intermediates useful in the process are disclosed.

  本发明涉及一般式为##STR1##的碳青霉烯类抗生素化合物，其中基团##STR2##是4、5或6成员的单、二或三取代氧或硫含环；其中Z是氧、硫、亚砜和磺酰基，所述药物组成物对治疗细菌感染有用，通过给予所述化合物抑制β-内酰胺酶酶的方法，揭示了制备该化合物的过程以及在该过程中有用的新中间体。
• Novel 2-thiosubstituted carbapenems
  申请人：AMERICAN CYANAMID COMPANY

  公开号：EP0617036A2

  公开（公告）日：1994-09-28

  Carbapenem antibiotic compounds of the general formula : wherein the moiety is a 4, 5 or 6 membered mono, di- or tri- substituted oxygen or sulfur containing ring ; wherein Z is oxygen, sulfur, sulfoxide and sulfone, pharmaceutical compositions thereof useful for the treatment of bacterial infections, processes for preparing the compounds and new intermediates useful in the process.

  通式为...的碳青霉烯类抗生素化合物 其中分子 其中 Z 是氧、硫、亚砜和砜；用于治疗细菌感染的药物组合物；制备该化合物的工艺以及在该工艺中有用的新中间体。